Tenaya Therapeutics (TNYA) Earnings Date & Reports

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TNYA is expected to report earnings to fall 24.61% to -21 cents per share on May 07

Tenaya Therapeutics TNYA Stock Earnings Reports

Q1'25

Est.

$-0.21

Q4'24

Beat

by $0.03

Q3'24

Beat

by $0.07

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.02

The last earnings report on March 10 showed earnings per share of -28 cents, beating the estimate of -31 cents. With 3.13M shares outstanding, the current market capitalization sits at 84.54M.

View a ticker or compare two or three

Compare

TNYA